The National Institute for Health and Care Excellence (NICE) has recommended cladribine (Mavenclad, Merck Serono) for adults in England with relapsing-remitting multiple sclerosis (RRMS).

The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...

Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...

Michael Castagna became CEO of MannKind and joined its board of directors in 2017, bringing 25+ years’ experience in ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

Dermatoscope imaging processed with AI has been in use in the UK for 4 years with accuracy shown to be at least equal to expert evaluation, leading to other advantages for the hospital system.

"The Board of Directors is pleased to welcome Ana Céspedes as the new CEO of Vitamin Angels," said Jim Hamilton, Chair of the Vitamin Angels Board of Directors. "Her strategic vision and proven track ...

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

DelveInsight's "TAGRISSO Market Size, Forecast, and Market Insight Report" highlights the details around TAGRISSO, a kinase ...